Cardiovascular Risk Through Optimal LDL-C Management Across the CVD Continuum

Overview

Cardiovascular disease (CVD) is still the leading cause of death and disability in the United States and LDL-Cholesterol is a major modifiable CVD risk factor and one of the key drivers of the atherosclerotic process. However, <1/3 of high-risk Americans are currently achieving their LDL-cholesterol goals. This session will review the new cholesterol guidelines from AHA/ACC and explore practical opportunities to improve LDL-C control across the continuum of cardiovascular risk.

The Family Heart Foundation is a non-profit, patient advocacy organization that supports people with inherited cholesterol disorders, including familial hypercholesterolemia (FH) and elevated Lp(a). Please join us for this engaging session to learn more about the new cholesterol guidelines and the latest research on the many innovative treatment options to control LDL-C.